Rep. April McClain Delaney Sells Off Shares of Labcorp Holdings Inc. (NYSE:LH)

Posted by Danessa Lincoln on Sep 12th, 2026

Representative April McClain Delaney (Democratic-Maryland) recently sold shares of Labcorp Holdings Inc. (NYSE:LH). In a filing disclosed on September 09th, the Representative disclosed that they had sold between $100,001 and $250,000 in Labcorp stock on August 25th.

Representative April McClain Delaney also recently made the following trade(s):

Sold $100,001 – $250,000 in shares of Wabtec (NYSE:WAB) on 8/25/2026.
Sold $100,001 – $250,000 in shares of Viking (NYSE:VIK) on 8/25/2026.
Sold $100,001 – $250,000 in shares of Trimble (NASDAQ:TRMB) on 8/25/2026.
Sold $100,001 – $250,000 in shares of Transdigm Group (NYSE:TDG) on 8/25/2026.
Sold $15,001 – $50,000 in shares of Tractor Supply (NASDAQ:TSCO) on 8/25/2026.
Sold $15,001 – $50,000 in shares of Middleby (NASDAQ:MIDD) on 8/25/2026.
Sold $15,001 – $50,000 in shares of Teledyne Technologies (NYSE:TDY) on 8/25/2026.
Sold $100,001 – $250,000 in shares of STERIS (NYSE:STE) on 8/25/2026.
Sold $100,001 – $250,000 in shares of Somnigroup International (NYSE:SGI) on 8/25/2026.
Sold $100,001 – $250,000 in shares of Signet Jewelers (NYSE:SIG) on 8/25/2026.

Labcorp Stock Up 1.4%

Shares of NYSE LH traded up $4.40 during mid-day trading on Friday, hitting $311.36. The company had a trading volume of 809,927 shares, compared to its average volume of 635,612. The company has a current ratio of 1.80, a quick ratio of 1.53 and a debt-to-equity ratio of 0.69. The firm has a 50-day simple moving average of $310.39 and a two-hundred day simple moving average of $281.94. The company has a market capitalization of $25.25 billion, a PE ratio of 25.75, a price-to-earnings-growth ratio of 1.74 and a beta of 0.88. Labcorp Holdings Inc. has a one year low of $244.52 and a one year high of $341.80.

Labcorp (NYSE:LH – Get Free Report) last posted its quarterly earnings results on Thursday, July 30th. The medical research company reported $4.99 earnings per share for the quarter, beating analysts’ consensus estimates of $4.78 by $0.21. The firm had revenue of $3.73 billion during the quarter, compared to the consensus estimate of $3.71 billion. Labcorp had a return on equity of 16.74% and a net margin of 6.99%.The business’s revenue was up 5.8% compared to the same quarter last year. During the same period last year, the company earned $4.35 earnings per share. Labcorp has set its FY 2026 guidance at 18.100-18.550 EPS. On average, equities analysts expect that Labcorp Holdings Inc. will post 18.32 EPS for the current year.

Labcorp Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 11th. Stockholders of record on Friday, August 28th will be paid a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Friday, August 28th. Labcorp’s dividend payout ratio is currently 23.82%.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of LH. Hilton Head Capital Partners LLC acquired a new stake in shares of Labcorp in the fourth quarter valued at approximately $27,000. JPL Wealth Management LLC bought a new position in Labcorp during the 3rd quarter worth $28,000. DV Equities LLC acquired a new position in Labcorp in the 4th quarter valued at $29,000. Allied Private Wealth LLC acquired a new position in Labcorp in the 2nd quarter valued at $33,000. Finally, EFG International AG bought a new stake in shares of Labcorp during the 4th quarter valued at $33,000. Institutional investors and hedge funds own 95.94% of the company’s stock.

Insider Activity at Labcorp

In related news, EVP Kathryn W. Kyle sold 92 shares of Labcorp stock in a transaction that occurred on Thursday, July 2nd. The shares were sold at an average price of $286.19, for a total value of $26,329.48. Following the transaction, the executive vice president directly owned 3,904 shares of the company’s stock, valued at $1,117,285.76. This trade represents a 2.30% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Kerrii B. Anderson sold 3,000 shares of the business’s stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $318.02, for a total transaction of $954,060.00. Following the transaction, the director owned 6,563 shares of the company’s stock, valued at approximately $2,087,165.26. This represents a 31.37% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 8,919 shares of company stock worth $2,826,593 in the last quarter. 0.84% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several research firms have issued reports on LH. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and set a $306.00 price target on shares of Labcorp in a research report on Friday, July 31st. Mizuho set a $355.00 target price on shares of Labcorp in a research note on Monday, August 10th. Piper Sandler lifted their price target on Labcorp from $300.00 to $309.00 and gave the stock a “neutral” rating in a report on Tuesday, August 4th. Wall Street Zen raised Labcorp from a “hold” rating to a “buy” rating in a research report on Sunday, July 12th. Finally, Barclays upped their price objective on Labcorp from $320.00 to $330.00 and gave the company an “equal weight” rating in a research note on Friday. Nine investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $336.36.

Read Our Latest Research Report on LH

Key Labcorp News

Here are the key news stories impacting Labcorp this week:

Positive Sentiment: Labcorp reaffirmed its 2026 guidance of adjusted EPS of $18.10 to $18.55, broadly consistent with the analyst consensus of $18.32. Maintaining guidance supports confidence in near-term earnings visibility. Labcorp Holdings Reiterates 2026 Outlook, Issues Long-Term Guidance
Positive Sentiment: The company issued a 2029 outlook calling for compound annual revenue growth of 5% to 8% and adjusted EPS growth of 8.5% to 11.5%. The targets imply sustained expansion beyond the current year and could support a higher long-term earnings outlook. Labcorp 2026 Investor Day Announcement
Positive Sentiment: Labcorp plans to use artificial intelligence, specialty testing, scientific capabilities and global scale to drive growth. Management also emphasized strong cash-flow generation and disciplined capital deployment, which may improve shareholder returns if execution meets expectations. Labcorp Bets Big on AI and Specialty Testing
Neutral Sentiment: The Investor Day transcript provided additional detail on Labcorp’s strategic priorities and long-term financial framework, but the benefits depend on successful implementation and investment in new technologies and testing capabilities. Labcorp Analyst and Investor Day Transcript
Negative Sentiment: LH recently declined about 4.3% and underperformed peers, indicating that investors may have viewed the Investor Day information as insufficient to justify the stock’s elevated valuation or may have taken profits despite the favorable long-term targets. Labcorp Stock Heads Into the Open After a 4.3 Percent Slide

About Representative McClain Delaney

April McClain-Delaney (Democratic Party) is a member of the U.S. House, representing Maryland’s 6th Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027.

McClain-Delaney (Democratic Party) is running for re-election to the U.S. House to represent Maryland’s 6th Congressional District. She declared candidacy for the 2026 election.

April McClain-Delaney grew up in Buhl, Idaho, where her father was a potato farmer. She obtained her bachelor’s degree in communications from Northwestern University in 1986 and her law degree from Georgetown Law Center in 1989. McClain-Delaney worked in communications law, first with the satellite firm Orion Network Systems and later as the Washington director for Common Sense Media, a nonprofit focused on technology and children. In 2022, McClain-Delaney joined the U.S. Department of Commerce under President Joe Biden (D) as deputy assistant secretary for communications and information. McClain-Delaney served on the board of the Georgetown University Law Center, the International Center for Research on Women, and the Northwestern University School of Communications.

About Labcorp

(Get Free Report)

Labcorp (NYSE: LH), formerly Laboratory Corporation of America Holdings, is a global life sciences and laboratory services company headquartered in Burlington, North Carolina. The company provides diagnostic testing and related services to physicians, hospitals, health systems, employers, government agencies and consumers.

Its diagnostics business offers routine and specialty laboratory testing, including molecular, genetic, oncology, women’s health, infectious disease and pathology services.